MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma

Published:2011-11 Issue:6 Volume:16 Page:368-372
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Olarte Irma¹,Martinez Adolfo¹,Ramos-Peñafiel Christian¹,Castellanos-Sinco Humberto¹,Zamora Jorge¹,Collazo-Jaloma Juan¹,Gutiérrez Mario¹,Gutiérrez-Kobeh Laila²,Chavez-Olmos Pedro³,Manzanilla Hugo⁴,Garrido-Guerrero Efraín³,Ordoñez-Razo Rosa M⁵,Miranda Enrique I¹⁶

Affiliation:

1. Laboratorio de Biología Molecular, Servicio de Hematología, Hospital General de México, México D.F., México

2. School of MedicineUNAM, México D.F., México

3. Departamento de Genética y Biología Molecular, CINVESTAV-IPN, México D.F., México

4. Servicio de Urología, Hospital General de México, México D.F., México

5. Unidad de Investigación Médica en Genética Humana, Hospital de Pediatría, Centro Médico Siglo XXI, IMSS, México D.F., México

6. School of MedicineWesthill University, México D.F., México

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1179/102453311X13085644680384

Reference31 articles.

1. Current Management of Mantle Cell Lymphoma

2. New Drugs for Myeloma

3. Diffuse large cell lymphoma

4. Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reconceiving Perineural Invasion in Cutaneous Squamous Cell Carcinoma: From Biological to Histopathological Assessment;Pathobiology;2024-07-24

2. Overexpression of BCL2, BCL6, VEGFR1 and TWIST1 in Circulating Tumor Cells Derived from Patients with DLBCL Decreases Event-Free Survival;OncoTargets and Therapy;2022-12

3. Nuclear overexpression levels of MAGE‐A3 predict poor prognosis in patients with prostate cancer;APMIS;2021-04-13

4. Immunological and functional aspects of MAGEA3 cancer/testis antigen;Advances in Protein Chemistry and Structural Biology;2021

5. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation;PLOS ONE;2020-11-23